30 / 12 / 2020
International Journal of Molecular Sciences
Lamin-Related Congenital Muscular Dystrophy Alters Mechanical Signaling and Skeletal Muscle Growth
Daniel J Owens, Julien Messéant, Sophie Moog, Mark Viggars...
Laminopathies are a clinically heterogeneous group of disorders caused by mutations in the LMNA gene, which encodes the nuclear envelope proteins lamins A and C. The most frequent diseases associated with LMNA mutations are characterized by skeletal and cardiac involvement, and include autosomal dominant Emery-Dreifuss muscular dystrophy (EDMD), limb-girdle muscular dystrophy type 1B, and LMNA-related congenital muscular dystrophy (LMNA-CMD).
03 / 12 / 2020
médecine/sciences
[Endosomal signaling by the TCR ζ chain is required for T lymphocyte survival in secondary lymphoid organs]
Irini Evnouchidou , Mathilde Nugue , Loredana Saveanu
L’élimination des cellules infectées ou cancéreuses dépend de la réponse immunitaire adaptative, qui est orchestrée par les lymphocytes T CD4+ et CD8+ et par les lymphocytes B producteurs d’anticorps. Les lymphocytes T forment une synapse immunologique avec les cellules infectées. Un facteur clé de cette synapse est l’interaction entre le récepteur de l’antigène exprimé à la surface du lymphocyte T (T cell receptor complex, ou « complexe TCR ») et les molécules du complexe majeur d’histocompatibilité (CMH) qui présentent des peptides antigéniques à la surface de la cellule infectée.
02 / 12 / 2020
Stem Cell Research
Generation of an iPSC line (IMAGINi011-A) from a patient carrying a STING mutation
Laura Barnabei, Mathieu Castela, Celine Banal, Nathalie Lefort, Frédéric Rieux-Laucat
Mutation in STING1gene, which encodes stimulator of type I IFN gene (STING) leads to its constitutive activation and thereby to a severe vasculopathy and sometimes a lupus-like disease. We generated induced pluripotent stem cells (iPSCs) from a patient carrying a rare heterozygous variant c.463G > A (resulting in a p.V155M substitution) in STING1.
17 / 11 / 2020
Biointerphases
Long-term hydrolytic degradation study of polycaprolactone films and fibers grafted with poly(sodium styrene sulfonate): Mechanism study and cell response
Leroux A, Ngoc Nguyen T, Rangel A, Cacciapuoti I, Duprez D, Castner DG, Migonney V.
Polycaprolactone (PCL) is a widely used biodegradable polyester for tissue engineering applications when long-term degradation is preferred. In this article, we focused on the analysis of the hydrolytic degradation of virgin and bioactive poly(sodium styrene sulfonate) (pNaSS) functionalized PCL surfaces under simulated physiological conditions (phosphate buffer saline at 25 and 37 °C) for up to 120 weeks with the aim of applying bioactive PCL for ligament tissue engineering.
20 / 10 / 2020
Frontiers in Molecular Bioscience
The Role of IRAP in Endocytic Trafficking and Receptor Signaling in Immune Cells
Descamps D, Evnouchidou I, Caillens V, Drajac C, Riffault S, van Endert P, Saveanu L.
IRAP is a type II transmembrane protein with broad tissue distribution initially identified as a major component of Glut4 storage vesicles (GSV) in adipocytes. Despite its almost ubiquitous expression, IRAP had been extensively studied mainly in insln responsive cells, such as adipocytes and muscle cells. In these cells, the enzyme displays a complex intracellular trafficking pattern regulated by insln. Early studies using fusion proteins joining the IRAP cytosolic domain to various reporter proteins, such as GFP or the transferrin receptor (TfR), showed that the complex and regulated trafficking of the protein depends on its cytosolic domain.
13 / 10 / 2020
Oncoimmunology
Immunity to live: an immunopathoscore using the consensus Immunoscore to best define the risk of recurrence and death in stage IV metastatic patients
Baldin P, Van den Eynde M, Mlecnik B, Galon J.
The consensus Immunoscore is a routine assay quantifying the adaptive immune response within the tumor microenvironment. Its evaluation in the primary tumor of patients with stages I/II/III colorectal cancer (CRC) has prognostic value that has been confirmed in multiple studies. For metastatic patients, the evaluation of the consensus Immunoscore within resected metastases also significantly predicts the recurrence and survival of Stage IV patients. Since recurrence rates post-surgery are still very high, it is important to best evaluate risk parameters using the main patho-molecular and immune parameters. After preoperative treatment and curative resection of 582 metastases from 221 patients, clinico-pathological parameters, RAS mutation, and Immunoscore within metastases were assessed.